Related Experiment Video
Updated: Aug 24, 2026

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
Published on: October 6, 2014
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
Ping Zhu1, Elke Martin, Jörg Mengwasser
1Institute of Toxicology and Genetics, Forschungszentrum Karlsruhe Branch, H.-v.-H.-Platz 1, D-76344 Eggenstein, Germany.
Abstract:
Inappropriate transcriptional repression involving histone deacetylases (HDACs) is a prominent cause for the development of leukemia. We now identify faulty expression of a specific mediator of transcriptional repression in a solid tumor. Loss of the adenomatosis polyposis coli (APC) tumor suppressor induces HDAC2 expression depending on the Wnt pathway and c-Myc. Increased HDAC2 expression is found in the majority of human colon cancer explants, as well as in intestinal mucosa and polyps of APC-deficient mice. HDAC2 is required for, and sufficient on its own to prevent, apoptosis of colonic cancer cells. Interference with HDAC2 by valproic acid largely diminishes adenoma formation in APC(min) mice. These findings point toward HDAC2 as a particularly relevant potential target in cancer therapy.
Insights
Faulty expression of histone deacetylase 2 (HDAC2) drives colon cancer by preventing cell death. Inhibiting HDAC2 with valproic acid reduced tumor formation in mice, suggesting HDAC2 as a potential cancer therapy target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Histone deacetylases (HDACs) are implicated in leukemia development through aberrant transcriptional repression.
- The role of specific HDACs in solid tumor development, particularly colon cancer, remains less understood.
Purpose of the Study:
- To investigate the role of a specific transcriptional repressor in solid tumor development.
- To determine the involvement of histone deacetylase 2 (HDAC2) in colon cancer pathogenesis.
- To evaluate HDAC2 as a potential therapeutic target for colon cancer.
Main Methods:
- Analysis of HDAC2 expression in human colon cancer samples and APC-deficient mouse models.
- Investigating the regulatory pathways (Wnt, c-Myc) influencing HDAC2 expression upon loss of the adenomatosis polyposis coli (APC) tumor suppressor.
- Assessing the effect of HDAC2 inhibition using valproic acid on tumor formation in APC(min) mice.
- Evaluating HDAC2's role in colon cancer cell apoptosis.
Main Results:
- Loss of the APC tumor suppressor induces HDAC2 expression, dependent on the Wnt pathway and c-Myc.
- Elevated HDAC2 expression is prevalent in human colon cancer tissues and APC-deficient mouse models.
- HDAC2 is essential for preventing apoptosis in colonic cancer cells.
- Valproic acid treatment significantly reduced adenoma formation in APC(min) mice.
Conclusions:
- HDAC2 plays a critical role in colon cancer progression by inhibiting apoptosis.
- Targeting HDAC2, potentially with drugs like valproic acid, shows promise for colon cancer therapy.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Anaphase Promoting Complex
Induced Pluripotent Stem Cells
Somatic cells are...
Hedgehog Signaling Pathway

